Balyasny Asset Management’s Aehr Test Systems AEHR Stock Holding History

Balyasny Asset Management’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,262	Closed	-$603K	–	2962
2026 Q1	$603K	Sell	16,262 -8,513	-34%	-$272K	﹤0.01%	2282
2025 Q4	$500K	Sell	24,775 -4,209	-15%	-$102K	﹤0.01%	2525
2025 Q3	$873K	Buy	+28,984	New	+$628K	﹤0.01%	2169
2025 Q1	–	Sell	-68,714	Closed	-$1.14M	–	2739
2024 Q4	$1.14M	Buy	68,714 +30,991	+82%	+$413K	﹤0.01%	1890
2024 Q3	$485K	Buy	37,723 +23,508	+165%	+$340K	﹤0.01%	2272
2024 Q2	$159K	Buy	+14,215	New	+$166K	﹤0.01%	2372
2024 Q1	–	Sell	-100,984	Closed	-$2.68M	–	2566
2023 Q4	$2.68M	Buy	+100,984	New	+$2.95M	0.01%	1358
2022 Q2	–	Sell	-11,965	Closed	-$122K	–	2703
2022 Q1	$122K	Buy	+11,965	New	+$153K	﹤0.01%	2111

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Balyasny Asset Management's AEHR Position: Q2 2026 in Review

Balyasny Asset Management sold out of Aehr Test Systems (AEHR) in Q2 2026, closing a stake of 16,262 shares — an estimated $603K sold.

Balyasny Asset Management first reported a position in AEHR in Q1 2022 and held it in 8 quarters. The position peaked at $2.68M in Q4 2023. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Balyasny Asset Management reported no remaining Aehr Test Systems position as of Q2 2026 after selling out during the quarter.
Balyasny Asset Management sold 16,262 Aehr Test Systems shares in Q2 2026, an estimated $603K.
Balyasny Asset Management first reported a position in Aehr Test Systems in Q1 2022 and held it in 8 quarters.
Balyasny Asset Management's Aehr Test Systems position peaked at $2.68M in Q4 2023.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.